Clinical trial • Phase I • Oncology
IPH4502 for Advanced Solid Tumors
Phase I trial of IPH4502 for Advanced Solid Tumors. 123 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced Solid Tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 27-11-2024
- First CTIS Authorization Date
- 13-03-2025
Trial design
Phase I trial across 2 sites in France.
- Target Sample Size
- 123
Recruitment
- Planned Sample Size
- 123
- Recruitment Window Months
- 37
Geography
- Total Number Of Sites
- 2
- Total Number Of Participants
- 22
France
- Earliest CTIS Part Ii Submission Date
- 11-02-2025
- Latest Decision Or Authorization Date
- 30-10-2025
- Processing Time Days
- 261
- Number Of Sites
- 2
- Number Of Participants
- 22
Sites
- Site Name
- Centre Leon Berard
- Department Name
- Medical Oncology
- Contact Person Name
- Armelle VINCENEUX
- Contact Person Email
- Armelle.Vinceneux@lyon.unicancer.fr
- Site Name
- Institut Gustave Roussy
- Department Name
- Early Drug Development and Genitourinary Oncology Group
- Contact Person Name
- Yohann LORIOT
- Contact Person Email
- Yohann.Loriot@gustaveroussy.fr
Sponsor
Primary sponsor
- Full Name
- Innate Pharma
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- France
Investigational products
- Investigational Product Name
- IPH4502
- First In Human
- Yes
Related trials
Other published trials that may interest you.